← Leaderboards
Mark H Greene
Cancer Epidemiology And Genetics
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Cancer Epidemiology And Genetics
Same institution · by research overlap
Others in their field
Top investigators on “Cancer Risk”
- Gregory H Reaman · National Childhood Cancer Foundation$242,495,090
- David Heimbrook · Leidos Biomedical Research, Inc.$222,048,828
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Philip J Disaia · University Of California Irvine$144,085,463
- Mitchell D Schnall · University Of Pennsylvania$138,156,012
- Peter C Adamson · National Childhood Cancer Foundation$128,266,602
Research focus
Cancer RiskMalignant NeoplasmsGenesCollaborationsGeneticBaseSeriesProspectiveMutationPublishingSamplingGenome Wide Association StudyManuscriptsPublicationsMalignant Breast NeoplasmGenetic SusceptibilityMutation CarrierCohortBreast NeoplasmsHuman SubjectNeoplasm /Cancer GeneticsOperative Surgical ProceduresParticipantWoman
Grant awards (44)
Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes$6,262,586
ZIA · FY2014 · CA · contact PI
Intervention Trials in Persons at Increased Genetic Risk of Cancer$534,681
ZIA · FY2014 · CA · contact PI
Genetic and Pharmacogenetic Modifiers of Cancer Risk and Intervention Outcomes$452,492
ZIA · FY2014 · CA · contact PI
Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes$5,155,247
ZIA · FY2013 · CA · contact PI
Intervention Trials in Persons at Increased Genetic Risk of Cancer$1,537,139
ZIA · FY2013 · CA · contact PI
Genetic and Pharmacogenetic Modifiers of Cancer Risk and Intervention Outcomes$615,071
ZIA · FY2013 · CA · contact PI
Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes$5,215,430
ZIA · FY2012 · CA · contact PI
Intervention Trials in Persons at Increased Genetic Risk of Cancer$1,567,046
ZIA · FY2012 · CA · contact PI
Genetic and Pharmacogenetic Modifiers of Cancer Risk and Intervention Outcomes$554,334
ZIA · FY2012 · CA · contact PI
Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes$3,997,558
ZIA · FY2011 · CA · contact PI
Intervention Trials in Persons at Increased Genetic Risk of Cancer$1,800,935
ZIA · FY2011 · CA · contact PI
Genetic and Pharmacogenetic Modifiers of Cancer Risk and Intervention Outcomes$622,843
ZIA · FY2011 · CA · contact PI
Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes$4,547,481
ZIA · FY2010 · CA · contact PI
Intervention Trials in Persons at Increased Genetic Risk of Cancer$1,490,914
ZIA · FY2010 · CA · contact PI
Genetic and Pharmacogenetic Modifiers of Cancer Risk and Intervention Outcomes$570,013
ZIA · FY2010 · CA · contact PI
Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes$5,624,794
ZIA · FY2009 · CA · contact PI
Intervention Trials in Persons at Increased Genetic Risk of Cancer$1,639,865
ZIA · FY2009 · CA · contact PI
Genetic and Pharmacogenetic Modifiers of Cancer Risk and Intervention Outcomes$68
ZIA · FY2009 · CA · contact PI
Intervention Trials in Persons at Increased Genetic Risk of Cancer$5,949,905
Z01 · FY2008 · CA · contact PI
Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes$667,799
Z01 · FY2008 · CA · contact PI
Genetic and Pharmacogenetic Modifiers of Cancer Risk and Intervention Outcomes$1,012
Z01 · FY2008 · CA · contact PI
Intervention Trials in Persons at Increased Genetic Risk of Cancer$3,238,292
Z01 · FY2007 · CA · contact PI
Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes$411,222
Z01 · FY2007 · CA · contact PI
Intervention Trials in Persons at Increased Genetic Risk$0
Z01 · FY2006 · CP · contact PI
Clinical Genetic Studies of Familial and Hereditary Canc$0
Z01 · FY2006 · CP · contact PI
Genetic and Pharmacogenetic Modifiers of Cancer Risk and$0
Z01 · FY2006 · CP · contact PI
Clinical Genetic Studies of Familial and Hereditary Canc$0
Z01 · FY2005 · CP
Intervention Trials in Persons at Increased Genetic Risk$0
Z01 · FY2005 · CP
Pharmacogenetic Determinants of Outcomes Following Treat$0
Z01 · FY2005 · CP
Clinical Genetic Studies of Familial &Hereditary Cancer$0
Z01 · FY2004 · CP
Intervention Trials in Persons w/ Genetic Risk of Cancer$0
Z01 · FY2004 · CP
Pharmacogenetic Determ. of Outcomes after Tx for Cancer$0
Z01 · FY2004 · CP
Clinical Genetic Studies of Familial / Hereditary Cancer$0
Z01 · FY2003 · CP
Intervention Trials in Persons at Increased Genetic Risk$0
Z01 · FY2003 · CP
Pharmacogenetic Determinants of Outcomes Following Treat$0
Z01 · FY2003 · CP
Clinical &Genetic Studies of Familial and Hereditary Ca$0
Z01 · FY2002 · CP
Intervention Trials in Persons at Increased Genetic Risk$0
Z01 · FY2002 · CP
Pharmacogenetic Determinants of Outcomes Following Cance$0
Z01 · FY2002 · CP
Clinical/Genetic Studies of Family/Hereditary Cancers$0
Z01 · FY2001 · CP
Interventions for People at Increased Risk of Cancer$0
Z01 · FY2001 · CP
Genetic Polymorphisms and Outcomes of Cancer Treatments$0
Z01 · FY2001 · CP
CLINICAL GENETIC STUDIES OF FAMILIAL &HEREDITARY CANCER$0
Z01 · FY2000 · CP
INTERVENTION TRIALS IN INCREASED GENETIC RISK OF CANCER$0
Z01 · FY2000 · CP
GENETIC POLYMORPHISMS AS DETERMINANTS OF OUTCOMES FOLLOW$0
Z01 · FY2000 · CP